Press release content from Business Wire. The AP news staff was not involved in its creation.
2021 Global Friedreich’s Ataxia Epidemiology and Patient Flow Report - ResearchAndMarkets.com
May 12, 2021 GMT
DUBLIN (BUSINESS WIRE) May 12, 2021
This research report provides Friedreich’s Ataxia epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.
The research provides population data to characterize Friedreich’s Ataxia patients, history of the disease at the population level (Friedreich’s Ataxia prevalence, Friedreich’s Ataxia incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.
Research and Markets: Global Non-Hodgkin Lymphoma Markets, Epidemiology and Patient Flow Report 2021 - ResearchAndMarkets.com
ResearchAndMarkets.com s offering.
Global Non-Hodgkin Lymphoma Epidemiology and Patient Flow Analysis 2021, provides Non-Hodgkin Lymphoma epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.
The research provides population data to characterize Non-Hodgkin Lymphoma patients, history of the disease at the population level (Non-Hodgkin Lymphoma prevalence, Non-Hodgkin Lymphoma incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.
Press release content from Business Wire. The AP news staff was not involved in its creation.
2021 Report on the Global Spinal Muscular Atrophy Market - Epidemiology and Patient Flow - ResearchAndMarkets.com
May 11, 2021 GMT
DUBLIN (BUSINESS WIRE) May 11, 2021
The research report provides Spinal Muscular Atrophy epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.
The research provides population data to characterize Spinal Muscular Atrophy patients, history of the disease at the population level (Spinal Muscular Atrophy prevalence, Spinal Muscular Atrophy incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.